[HTML][HTML] Current treatment strategies for COVID‑19
F Han, Y Liu, M Mo, J Chen… - Molecular …, 2021 - spandidos-publications.com
The spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2)
emerged suddenly at the end of 2019 and the disease came to be known as coronavirus …
emerged suddenly at the end of 2019 and the disease came to be known as coronavirus …
Coronavirus disease 2019 (COVID-19): a clinical update
M Zhou, X Zhang, J Qu - Frontiers of medicine, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It …
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It …
[HTML][HTML] Is teicoplanin a complementary treatment option for COVID-19? The question remains
We read with great interest the editorial by Baron et al. suggesting the potential use of
teicoplanin as an alternative drug to treat patients infected with severe acute respiratory …
teicoplanin as an alternative drug to treat patients infected with severe acute respiratory …
Coronavirus disease 2019 (COVID-19): current status and future perspectives
H Li, SM Liu, XH Yu, SL Tang, CK Tang - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …
quickly spread globally. Several treatments have been proposed, many of which have …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
COVID-19: emergence, spread, possible treatments, and global burden
The Coronavirus (CoV) is a large family of viruses known to cause illnesses ranging from the
common cold to acute respiratory tract infection. The severity of the infection may be visible …
common cold to acute respiratory tract infection. The severity of the infection may be visible …
[PDF][PDF] Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
T Zhang, Y He, W Xu, A Ma, Y Yang… - Science China. Life …, 2020 - med.uminho.pt
Emerging coronavirus disease 2019, known as COVID-19, is caused by the newly identified
SARS-CoV-2 virus. Since the outbreak of COVID-19 in December 2019 in Wuhan (China) …
SARS-CoV-2 virus. Since the outbreak of COVID-19 in December 2019 in Wuhan (China) …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
[HTML][HTML] Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - International journal of antimicrobial agents, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …